|
|
|
|
|
|
|
|
|
|
|
|
Cardiac CryoAblation Catheter system receives US FDA approval |
|
|
| Balloons
: 21 December, 2010 |
|
The US Food and Drug Administration (FDA) approves Medtronic’s Arctic Front Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). |
| |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Abiomed plans multi-site trial to assess if Impella 2.5 can shrink infarct size |
|
|
|
| Cardiac devices and equipment
: 06 December, 2010 |
|
Abiomed receives conditional approval from the US Food and Drug Administration to begin MINI-AMI, a prospective, randomized, controlled multi-site trial to assess the potential role of the Impella 2.5 in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI). |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Display controllers deliver better performance for medical imaging |
|
|
|
| Electronic components
: 29 November, 2010 |
|
Barco introduces a new range of display controllers for medical imaging that deliver triple-head capabilities and better performance when handling large datasets as well as faster OpenGL and DirectX functionality, all of which are becoming increasingly common in high-end PACS environments. |
| |
|
|
|
|
|
|
|
|
|
|
|
RCRMC deploys Barco medical imaging displays throughout the medical centre |
|
|
|
| Displays and monitors
: 22 November, 2010 |
|
Barco completes a hospital-wide deployment of medical imaging displays at Riverside County Regional Medical Center, with a concentration in their surgical suites, the emergency department, radiology reading rooms, mammography, and outpatient clinics throughout the medical centre. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
HeartWare International reveals data from bridge to heart transplantation study |
|
|
|
| Cardiac devices and equipment
: 16 November, 2010 |
|
Data from HeartWare International’s bridge to heart transplantation (BTT) study, ADVANCE, shows that 92 percent of the investigational device patients met the per protocol primary endpoint of the trial, which was defined as alive on the originally implanted device, transplanted or explanted for recovery at 180 days. |
| |
|
|
|
|
|
|
|
ASSERT clinical trial focuses on pacemaker benefits for asymptomatic AF patients |
|
|
|
| Cardiac devices and equipment
: 16 November, 2010 |
|
St Jude Medical reveals the results of the ASymptomatic AF and Stroke Evaluation in Pacemaker Patients and the AF Reduction Atrial Pacing Trial (ASSERT), a St Jude Medical sponsored trial conducted by the Population Health Research Institute of McMaster University and Hamilton Health Sciences in Hamilton, Canada. |
| |
|
|
|
|
|
|
|
BIOLUX P-I clinical study begins patient enrollment |
|
|
|
| Catheters
: 08 November, 2010 |
|
Biotronik announces the first patient enrollment in the BIOLUX P-I clinical study which is a randomized controlled study investigating the safety and performance of the Biotronik Passeo-18 Lux, a drug-eluting balloon (DEB) catheter, versus a noncoated percutaneous transluminal angioplasty (PTA) catheter, for the treatment of lesions in the femoropopliteal segment. |
| |
|
|
|
|
|
|
|
|
|
Boston Scientific acquires Asthmatx |
|
|
|
| Catheters
: 28 October, 2010 |
|
Boston Scientific completes its acquisition of Asthmatx of Sunnyvale, California, which designs, manufactures and markets the Alair Bronchial Thermoplasty System, a catheter-based procedure for the treatment of severe persistent asthma in the six to eight million patients 18 years and older worldwide whose asthma is not well controlled with drugs (inhaled medications). |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
St Jude Medical plans to acquire AGA Medical to address structural heart market |
|
|
|
| Cardiac devices and equipment
: 20 October, 2010 |
|
The Boards of Directors of St Jude Medical and AGA Medical Holdings approve a definitive agreement under which St Jude Medical will acquire all of the outstanding shares of AGA Medical for $20.80 per share in a cash and stock transaction valued at approximately $1.3 billion, including the assumption of approximately $225 million in outstanding debt. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large-scale study highlights performance benefits of vascular closure device |
|
|
|
| Cardiac devices and equipment
: 23 September, 2010 |
|
St Jude Medical releases subset data results for the Angio-Seal Evolution Vascular Closure Device Registry which reaffirm the excellent sealing performance of the Angio-Seal Evolution vascular closure device in patients undergoing routine diagnostic and interventional cardiac catheterization procedures. |
| |
|
|
|
|
|
|
|
Cook's antibiotic impregnated PICCs target bloodstream infections |
|
|
|
| Catheters
: 22 September, 2010 |
|
Cook Medical expands the company’s Spectrum Turbo-Ject line of antibiotic impregnated peripherally inserted central venous catheters (PICCs) to treat a wider range of patient needs and is in response to increased demand for technology to help prevent potentially fatal catheter-related bloodstream infections (CRBSIs). |
| |
|
|
|
|
|
|
|
Boston Scientific seeks to acquire Asthmatx |
|
|
|
| Catheters
: 21 September, 2010 |
|
Boston Scientific signs a definitive merger agreement, under which Boston Scientific will acquire Asthmatx, a privately held company in Sunnyvale, California, USA. |
| |
|
|
|
|
|
|
|
|
|
Handheld oximeters enables transfer of secure data |
|
|
|
| Pulse oximeters
: 20 September, 2010 |
|
Nonin Medical introduces the company’s latest Continua Certified device, the 1000USB-C USB adapter, which is designed for OEM system developers, enables any of Nonin's handheld oximeters to transfer secure data in accordance with Continua Health Alliance guidelines. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| First | Prev | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | Next | Last |
